The study employed a dose-escalation protocol to mitigate gastrointestinal side effects: Weeks 04: 2 mg once weekly (for groups escalating to 4 mg, 8 mg, or 12 mg) Weeks 58: 4 mg once weekly (for groups escalating to 8 mg or 12 mg) Weeks 912: 8 mg once weekly (for the 12 mg group only) Weeks 1348: Maintenance dose (4 mg, 8 mg, or 12 mg depending on group assignment) This gradual escalation reduced the incidence and severity of nausea compared to immediate initiation at higher doses
Recommended Retatrutide Dosing Schedule and Titration Guidance In Phase 2 trials, retatrutide was titrated from a starting dose of 0.5 mg once weekly, with incremental increases at approximately four-weekly intervals to maintenance doses of 4 mg, 8 mg, or 12 mg
critical revision of the manuscript for important intellectual content
Tingley, Sex differences in GLP-1 signaling across species
Peak Wellness offers a money-back guarantee, though specific terms and conditions apply
How Much Does It Typically Cost